JP2007508316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007508316A5 JP2007508316A5 JP2006534418A JP2006534418A JP2007508316A5 JP 2007508316 A5 JP2007508316 A5 JP 2007508316A5 JP 2006534418 A JP2006534418 A JP 2006534418A JP 2006534418 A JP2006534418 A JP 2006534418A JP 2007508316 A5 JP2007508316 A5 JP 2007508316A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- substance according
- substance
- overexpression
- erbb2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51060403P | 2003-10-10 | 2003-10-10 | |
| PCT/US2004/033355 WO2005034879A2 (en) | 2003-10-10 | 2004-10-08 | Treatment of diseases involving erbb2 kinase overexpression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007508316A JP2007508316A (ja) | 2007-04-05 |
| JP2007508316A5 true JP2007508316A5 (enExample) | 2007-11-29 |
Family
ID=34435110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006534418A Abandoned JP2007508316A (ja) | 2003-10-10 | 2004-10-08 | ＥｒｂＢ２キナーゼ過剰発現に関連する病気の治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050245601A1 (enExample) |
| EP (1) | EP1670455A4 (enExample) |
| JP (1) | JP2007508316A (enExample) |
| CN (1) | CN1889944A (enExample) |
| AU (1) | AU2004280257A1 (enExample) |
| CA (1) | CA2541548A1 (enExample) |
| IL (1) | IL174763A0 (enExample) |
| RU (1) | RU2006115615A (enExample) |
| WO (1) | WO2005034879A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006263669B9 (en) * | 2005-06-29 | 2012-12-13 | Mars, Incorporated | Inducing peripheral blood vessel vasodilation |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP2275096A3 (en) | 2005-08-26 | 2011-07-13 | Braincells, Inc. | Neurogenesis via modulation of the muscarinic receptors |
| WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| EP2004208B1 (en) * | 2005-12-23 | 2017-01-25 | Mars, Incorporated | Skin protection and improvement |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| EP2021000A2 (en) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| WO2008030651A1 (en) * | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| CN101918844A (zh) * | 2007-06-18 | 2010-12-15 | 米迪缪尼有限公司 | 表达epha2和erbb2的细胞的协同治疗 |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554645A (en) * | 1994-10-03 | 1996-09-10 | Mars, Incorporated | Antineoplastic cocoa extracts and methods for making and using the same |
| CN1159019C (zh) * | 1996-04-02 | 2004-07-28 | 火星有限公司 | 可提取物化合物以及其制备方法和用途 |
| US6297273B1 (en) * | 1996-04-02 | 2001-10-02 | Mars, Inc. | Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions |
| US6207842B1 (en) * | 1997-10-09 | 2001-03-27 | Mars Incorporated | Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives |
| US6156912A (en) * | 1999-04-09 | 2000-12-05 | Mars, Incorporated | 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation |
| US7015338B1 (en) * | 1999-04-15 | 2006-03-21 | Mars Incorporated | Synthetic methods for preparing procyanidin oligomers |
-
2004
- 2004-10-08 RU RU2006115615/14A patent/RU2006115615A/ru not_active Application Discontinuation
- 2004-10-08 AU AU2004280257A patent/AU2004280257A1/en not_active Abandoned
- 2004-10-08 CA CA002541548A patent/CA2541548A1/en not_active Abandoned
- 2004-10-08 CN CNA2004800362204A patent/CN1889944A/zh active Pending
- 2004-10-08 JP JP2006534418A patent/JP2007508316A/ja not_active Abandoned
- 2004-10-08 EP EP04809906A patent/EP1670455A4/en not_active Withdrawn
- 2004-10-08 US US10/961,992 patent/US20050245601A1/en not_active Abandoned
- 2004-10-08 WO PCT/US2004/033355 patent/WO2005034879A2/en not_active Ceased
-
2006
- 2006-04-03 IL IL174763A patent/IL174763A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2365372C2 (ru) | Циклические ингибиторы протеинтирозинкиназ | |
| Cheng et al. | The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells | |
| WO2008008315A3 (en) | Compositions and methods for inhibiting growth of smad4-deficient cancers | |
| TW200628469A (en) | Disubstituted pyrazolobenzodiazepines | |
| IL184872A0 (en) | Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers | |
| MX2007013632A (es) | Procedimientos para preparar derivados de bencil-benceno sustituidos con glucopiranosilo y sus productos intermedios. | |
| JP2010501572A5 (enExample) | ||
| MX2007002398A (es) | Nuevas composiciones farmaceuticas para el tratamiento de cancer. | |
| ATE469158T1 (de) | Heteroalkylgebundene pyrimidinderivate | |
| CY1112570T1 (el) | Θεραπεια καρκινων με μετασταση | |
| RU2012110580A (ru) | Способы скрининга in vivo | |
| JP2010540556A5 (enExample) | ||
| CY1111065T1 (el) | Φαρμακευτικη συνθεση που περιεχει μια ωμεγα-καρβοξυαρυλ υποκατεστημενη διφαινυλ ουρια για τη θεραπευτικη αντιμετωπιση του καρκινου | |
| UA107675C2 (xx) | Застосування n-(4-((3-(2-аміно-4-піримідиніл)-2-піридиніл)окси)феніл)-4-(4-метил-2-тієніл)-1-фталазинаміну для лікування раку, рефрактерного до лікування протираковим агентом | |
| RU2006115615A (ru) | Лечение заболеваний, в патогенез которых вовлечена гиперэкспрессия киназы erbb2 | |
| MX2008002104A (es) | Derivados de 1-acildihidropirazol. | |
| WO2005085188A3 (en) | Compounds and methods for anti-tumor therapy | |
| JP2010510217A5 (enExample) | ||
| EP2399611A3 (en) | Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formaton of metasatases in cancer treatment | |
| Park et al. | Anticancer effects of genistein, green tea catechins, and cordycepin on oral squamous cell carcinoma | |
| JP2005525397A5 (enExample) | ||
| WO2007044450A3 (en) | Compositions and methods for the treatment of cancer | |
| ATE435224T1 (de) | Neue piperidinsubstituierte diaminothiazole | |
| CA2656005A1 (en) | Chemotherapeutic compounds for selectively targeting tumor cells with fr type receptors | |
| WO2011076095A8 (en) | Methods and compositions related to reduced met phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells |